Hepalink (9989) announces final dividend for 2024

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has announced a final dividend of RMB 2.5 per 10 shares for the financial year ending December 31, 2024, as approved by shareholders on May 22, 2025. The dividend, categorized as ordinary, will be paid on July 7, 2025. The Hong Kong dollar equivalent is HKD 2.7165 per 10 shares, based on an exchange rate of RMB 1: HKD 1.0866. The ex-dividend date is set for May 26, 2025, and the record date for determining entitlement is May 30, 2025. The book close period will span from May 28, 2025, to May 30, 2025. Tricor Investor Services Limited is the share registrar. The announcement also details withholding tax implications for various categories of shareholders, including resident, non-resident enterprises, and individual investors.